1 / 31

Liver function test

Liver function test. Part 1 Liver enzyme(ALT-AST-ALP-GGT). Liver is the largest Organ of the body weighing about 1.5 Kg. Liver is called kitchen of our body. Major Metabolic Functions of the Liver. Synthetic Function

jwetmore
Télécharger la présentation

Liver function test

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Liver function test Part 1 Liver enzyme(ALT-AST-ALP-GGT)

  2. Liver is the largest Organ of the body weighing about 1.5 Kg. • Liver is called kitchen of our body.

  3. Major Metabolic Functions of the Liver • Synthetic Function • Plasma proteins (albumin, globulins), cholesterol, triglycerides and lipoproteins • Detoxification and excretion • Ammonia to urea (urea cycle), bilirubin, cholesterol, drug metabolites • Storage Function • Vitamins A, D, E, K and B12 • Production of bile salts • Helps in digestion

  4. Liver Function Tests (LFTs) • Noninvasive methods for screening of liver dysfunction • Help in identifying general types of disorder • Assess severity and allow prediction of outcome • Disease and treatment follow up

  5. Liver Function Tests (LFTs) Broadly classified as: • Tests to detect hepatic injury: • Mild or severe; acute or chronic • Nature of liver injury (hepatocellular or cholestasis) • Tests to assess hepatic function

  6. Classification of LFTs Group I: Markers of liver dysfunction • Serum bilirubin: total and conjugated • Urine: bile salts and urobilinogen • Total protein, serum albumin and albumin/globulin ratio • Prothrombin Time

  7. Classification of LFTs Group II: Markers of hepatocellular injury • Alanine aminotransferase (ALT) • Aspartate aminotransferase (AST)

  8. Classification of LFTs Group III: Markers of cholestasis • Alkaline phosphatase (ALP) • g-glutamyltransferase (GGT)

  9. Liver Enzymes

  10. Aminotranferases • Aminotransferases or transaminases are a group of enzymes that catalyze the interconversion of amino acids and ketoacids (oxoacids) by transfer of amino group • The two aminotransferases of greatest clinical significance are: • Aspartate aminotransferase (AST), formerly termed glutamate oxaloacetate transaminase (GOT). • Alanine aminotransferase (ALT), formerly termed glutamate pyruvate transaminase (GPT). • Pyridoxal phosphate (P-5-P) is coenzyme

  11. Aspartate aminotransferase (AST) • AST involved in the transfer of an amino group between aspartate and -ketoacids. • Mohammed Laqqan

  12. Clinical Significance • Aspartate aminotransferase (AST) is an enzyme found primarily in the heart, liver, and muscle. • Additional AST is released into the circulation after injury or death of cells. • This test is one of several that are performed when there has been damage to the heart muscle, as in myocardial infarction, and in assessing liver damage. • Infants levels approximately twice the adult level, these decline to adult levels by approximately 6 months of age. • Mohammed Laqqan

  13. Specimen Collection • Specimen: • Serum, heparin plasma or EDTA plasma • Hemolysis should be avoided because it can dramatically increase serum AST concentrations • (RBCs contain 15 X the AST activity in serum) • Mohammed Laqqan

  14. Assay for Enzyme activity • Measurement by Karmen method • A coupled reaction involving: • pyridoxal-5-phosphate (P-5-P) • and malate dehydrogenase (MDH) • at 37oC: • Decrease in absorbance at 340 nm is determined by continuous monitoring. AST Aspartate + -Ketoglutarate Oxaloacetate + Glutamate Oxaloacetate + NADH + H Malate + NAD MD • Mohammed Laqqan

  15. Normal range: 8 – 20 U/L • Post AMI • Rises 6 – 8 hours • Peaks at 24 hours • Returns to normal by day 5 • AST levels are highest in acute hepatocellular disorders "viral hepatitis, cirrhosis.

  16. Alanine Aminotransferase (ALT) • A transferase with enzymatic activity similar to AST • Converts alanine + α-ketoglutarate to pyruvate and glutamate • Mohammed Laqqan

  17. Clinical Significance • It is found in the kidneys, heart, and skeletal muscle tissue but primarily in liver tissue. • The test is used mainly in the diagnosis of liver disease and to monitor the effects of hepatotoxic drugs. • Often higher than AST with liver damage and tend to remain elevated longer(More liver-specific than AST) • Remains normal in AMI • Mohammed Laqqan

  18. Specimen Collection • Specimen: • Serum, heparin plasma or EDTA plasma • Hemolysis should be avoided because it can increase serum ALT concentrations • (ALT in RBCs is roughly 5 X that of serum) • Mohammed Laqqan

  19. Assay for enzyme activity ALT Alanine + -Ketoglutarate Pyruvate + Glutamate Pyruvate + NADH + H Lactate + NAD LD • The most common method in use today for measurement of ALT activity utilizes a coupled enzymatic procedure for monitoring disappearance of NADH. • In this approach lactate dehydrogenase (LDH) and its required cofactors are added and catalyze the conversion of pyruvate to lactate • This causes simultaneous oxidation of reduced nicotinamide adenine dinucleotide (NADH). • The disappearance of NADH is followed spectrophotometrically (at 340 nm).

  20. Normal range (U/L): • Male: 13-35 • Female: 10-30 • High serum levels in acute hepatitis (300-1000U/L) • Moderate elevation in alcoholic hepatitis (100-300U/L) • Minor elevation in cirrhosis, hepatitis C and non-alcoholic steatohepatitis (NASH) (50-100U/L)

  21. Levels of AST & ALT • AST is assessed along ALT in monitoring liver damage. • These two values normally exist in an approximately 1:1 ratio. • As a rough guide: • AST>ALT in: • alcoholic hepatitis and cirrhosis, • metastatic cancer of the liver • non-biliary cirrhosis, • while ALT>AST in: • viral and drug hepatitis, • chronic hepatitis C • and hepatic obstruction. • Mohammed Laqqan

  22. Alkaline Phosphatase (ALP) • Phosphatases transfer a phosphate moiety from one group to a second, forming an alcohol and a second phosphate compound. • The optimal reaction pH for ALP is between 9 and 10 and varies with the buffer and substrate. • ALP requires Mg2+ as an activator • Mohammed Laqqan

  23. Isoenzymes • ALP exists as a number of isoenzymes • Major are those found in Liver, bone, placenta, and then intestinal fraction • Electrophoresis for isoenzyme analysis • Liver isoenzyme (fastest) • Bone isoenzyme • Placental isoenzyme • Intestinal isoenzyme (slowest) • Immunochemical methods now available • Mohammed Laqqan

  24. Clinical Significance • Alkaline phosphatase (ALP) is an enzyme found in the liver, bone, placenta, intestine, and kidneys • Primarily in the cells lining the biliary tract and in the osteoblasts involved in the formation of new bone. • ALP is normally excreted from the liver in the bile. • Increased ALP levels are found most commonly during: • periods of bone growth (as in children), • in various types of liver disease, • and in biliary obstruction. • Serum ALP activity primarily reflects changes in bone and liver function, even though higher ALP activities can be found in other organs. • Mohammed Laqqan

  25. Specimen Collection • Blood should be drawn after a fast of at least 8 hours. • Serum or heparinized plasma. • Slight hemolysis is tolerable, but gross hemolysis should be avoided. • These increases may be caused by: • the release of ALP from complexes with lipoproteins, • It is best to analyze ALP specimens the same day they are drawn. • ALP is inhibited by metal-complexing anticoagulants; EDTA, oxalate, and citrate inhibit the enzyme by complexing Mg2+ and should not be used. • Mohammed Laqqan

  26. Assay for Enzyme activity • almost all assays for ALP employ p-nitrophenyl phosphate as the substrate. • Bowers and Combs method based on absorption of p-nitrophenol at 405 nm • At an alkaline pH, • p-nitrophenyl phosphate is colorless; • the product p-nitrophenol is intensely yellow

  27. Normal range: 40 – 125 U/L

  28. γ-Glutamyltransferase (GGT) • Transfers γ-glutamyl residue from γ-glutamyl peptides (usually glutathione) to amino acids, H2O and other small peptides • glutathione serves as the γ-glutamyl donorGlutathione + Amino Acid glutamyl-peptide + L-cysteinylglycine • High concentrations in liver tissue • Also in pancreas and kidney GGT

  29. Diagnostic Significance • Increased plasma GGT is associated with • Hepatobiliary disease • Highest seen in biliary obstruction • Alcoholic cirrhosis • Used with ALP to differentiate between liver and bone diseases

  30. Assay for enzyme activity • γ- glutamyl residue of γ glutamyl-p-nitroanilide is transferred to glycylglycine, releasing p-nitroaniline L-γ-glutamyl-p-nitroanilide + glycylglycine p-nitroaniline + y-glutamylglycylglycine • The rate of liberation of p-nitroaniline is directly related to the GGT activity in the sample and is quantitated by measuring the increase in absorbance at 405 nm. GGT Reference Range: male, 6-45 U/L (37°C); female, 5-30 U/L (37°C)

More Related